[go: up one dir, main page]

WO2008062453B1 - Composition contenant de la nicotine base, des huiles aromatiques et du salicylate d'alkyle pour l'administration de nicotine base sous forme de vapeur - Google Patents

Composition contenant de la nicotine base, des huiles aromatiques et du salicylate d'alkyle pour l'administration de nicotine base sous forme de vapeur

Info

Publication number
WO2008062453B1
WO2008062453B1 PCT/IN2007/000439 IN2007000439W WO2008062453B1 WO 2008062453 B1 WO2008062453 B1 WO 2008062453B1 IN 2007000439 W IN2007000439 W IN 2007000439W WO 2008062453 B1 WO2008062453 B1 WO 2008062453B1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
salicylate
nicotine base
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000439
Other languages
English (en)
Other versions
WO2008062453A2 (fr
WO2008062453A3 (fr
Inventor
Nikki Nikhilesh Singh
Umesh Shantisingh Tomar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008062453A2 publication Critical patent/WO2008062453A2/fr
Publication of WO2008062453A3 publication Critical patent/WO2008062453A3/fr
Publication of WO2008062453B1 publication Critical patent/WO2008062453B1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un procédé pour administrer de la nicotine base sous forme de vapeur à partir d'une composition contenant la nicotine base et un salicylate d'alkyle. Le salicylate de méthyle est le salicylate d'alkyle préféré. Des ingrédients facultatifs dans la composition comprennent des composés aromatiques tels que le menthol, le camphre, et diverses autres huiles essentielles. Le procédé est particulièrement utile comme aide à l'arrêt du tabagisme, pour le traitement du tabagisme et de l'addiction à d'autres produits à base de tabac. Un moyen préféré d'administration de la nicotine base sous forme de vapeur dans le traitement de l'arrêt du tabagisme et de l'addiction au tabac est un inhalateur de vapeur.
PCT/IN2007/000439 2006-09-25 2007-09-19 Composition contenant de la nicotine base, des huiles aromatiques et du salicylate d'alkyle pour l'administration de nicotine base sous forme de vapeur Ceased WO2008062453A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1525/MUM/2006 2006-09-25
IN1525MU2006 2006-09-25

Publications (3)

Publication Number Publication Date
WO2008062453A2 WO2008062453A2 (fr) 2008-05-29
WO2008062453A3 WO2008062453A3 (fr) 2008-09-18
WO2008062453B1 true WO2008062453B1 (fr) 2008-11-20

Family

ID=39367499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000439 Ceased WO2008062453A2 (fr) 2006-09-25 2007-09-19 Composition contenant de la nicotine base, des huiles aromatiques et du salicylate d'alkyle pour l'administration de nicotine base sous forme de vapeur

Country Status (1)

Country Link
WO (1) WO2008062453A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009047779A2 (fr) * 2007-06-20 2009-04-16 Nikki Nikhilesh Singh Composition contenant des huiles aromatiques de fentanyl base et un salicylate d'alkyle pour la libération de fentanyl base sous forme vapeur
BR122023020807A2 (pt) * 2016-04-12 2023-12-12 Arturo Solis Herrera Uso de agonistas do receptor de acetilcolina nicotínica no tratamento de uma condição de uma membrana mucosa nasal ou paranasal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73912A0 (en) * 1984-01-09 1985-03-31 Advanced Tobacco Prod Nicotine preparation
JP2004229627A (ja) * 2003-01-29 2004-08-19 Yoshiaki Fujiyama 鼻で吸うタバコ代用物
DE10356925B4 (de) * 2003-12-05 2006-05-11 Lts Lohmann Therapie-Systeme Ag Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung

Also Published As

Publication number Publication date
WO2008062453A2 (fr) 2008-05-29
WO2008062453A3 (fr) 2008-09-18

Similar Documents

Publication Publication Date Title
KR101170844B1 (ko) 경점막 약물 전달 시스템
JP5524442B2 (ja) 呼吸器疾患の治療のための、抗コリン作用薬及びβ−模倣薬の新規併用薬
JP4500045B2 (ja) 感冒の治療のための組成物
AU2002318211A1 (en) Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
JP2007507538A5 (fr)
CA2452872A1 (fr) Administration parenterale de 6-hydroxy-oxymorphone destinee a etre utilisee en tant qu'analgesique
TW200407142A (en) New formulation and use thereof
MX2009009131A (es) Mejoras en y con relacion a composiciones medicinales.
WO2006058249A3 (fr) Procedes et compositions destines a decourager l'abus de produits pharmaceutiques administres oralement
CA2344637A1 (fr) Aerosols-doseurs pour solution de delta9-tetrahydrocannabinol (.delta.9thc) et leur mode d'utilisation
US20040209850A1 (en) Methods of treating pain and compositions for use therefor
MX2012013380A (es) Atomizador nasal liquido que contiene naltresona de dosis baja.
EP1515711A1 (fr) Composition pharmaceutique
MXPA05009629A (es) Composiciones que contienen trospio.
CA2469200A1 (fr) Systemes d'administration d'analgesiques et methodes d'utilisation
Islam et al. Improved treatment of nicotine addiction and emerging pulmonary drug delivery
IE920484A1 (en) Pharmaceutical Formulations
US20100029771A1 (en) Treatment of addictive disorders
CA2483090A1 (fr) Utilisation de compositions therapeutiques a base de 1,2,3,6-tetrahydropyrimidine-2-one
CN113453665A (zh) 用于舌下和/或经颊施用的纳洛酮制剂
JP2008115167A (ja) トラネキサム酸を含有する気道杯細胞過形成抑制剤
WO2008062453B1 (fr) Composition contenant de la nicotine base, des huiles aromatiques et du salicylate d'alkyle pour l'administration de nicotine base sous forme de vapeur
TW201900215A (zh) 用於治療類風濕性關節炎之組合物及方法
MXPA06009094A (es) Formulaciones de liberacion controlada.
WO2010025505A1 (fr) Analgésie par administration transmuqueuse

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07866710

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07866710

Country of ref document: EP

Kind code of ref document: A2